Novartis AG (NVS) Earnings
|
Expand Research on NVS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +3.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/19/22 | Q222 | N/A | $1.52 | N/A | N/A | $13B | N/A | N/A | N/A | ||
| 4/26/22 |  |
Q122 | $1.46 | $1.44 | +$0.02 | $12.53B | $12.73B | N/A |  | | Details |
| 2/2/22 | |
Q421 | $1.40 | $1.41 | -$0.01 | $13.23B | $13.29B | N/A | | | Details |
10/26/21  |
|
Q321 | N/A | $1.65 | N/A | N/A | $13.03B | N/A | N/A | N/A | |
| 7/21/21 |
|
Q221 | N/A | $1.52 | N/A | N/A | $12.51B | N/A | N/A | N/A | |
| 4/27/21 |
|
Q121 | N/A | $1.59 | N/A | N/A | $12.51B | N/A | N/A | N/A | |
| 1/26/21 |
Q420 | N/A | $1.36 | N/A | N/A | $12.87B | N/A | N/A | N/A | ||
| 10/27/20 |
Q320 | N/A | $1.45 | N/A | N/A | $12.53B | N/A | N/A | N/A |
